Literature DB >> 9144507

Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages.

J Y Jeong1, D M Jue.   

Abstract

TNF, a potent immunoregulatory cytokine, is associated with inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, and cerebral malaria when produced in excess. Antimalarial agents such as chloroquine and hydroxychloroquine have been used to treat some rheumatic diseases. Chloroquine was reported to inhibit production of TNF, although the underlying mechanism is poorly understood. In RAW 264.7 cells stimulated with LPS, addition of chloroquine at nontoxic concentrations did not inhibit induction of TNF mRNA and NF-kappaB activity. In the same cells, synthesis and steady state level of 26-kDa pro-TNF were also not significantly reduced by addition of chloroquine, while only small amount of 17-kDa mature TNF was detected in the medium. A pulse-chase experiment of pro-TNF produced in chloroquine-treated cells showed significant inhibition of processing of prohormone. Hydroxychloroquine showed similar inhibitory effect, whereas other lysosomal inhibitors such as ammonium chloride and methylamine had no effect on the production of TNF. Our results suggest that chloroquine inhibits production of TNF at the step of processing of membrane-bound pro-TNF to make soluble mature protein in a lysosome-independent manner.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144507

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Azithromycin distinctively modulates classical activation of human monocytes in vitro.

Authors:  M Vrančić; M Banjanac; K Nujić; M Bosnar; T Murati; V Munić; D Stupin Polančec; D Belamarić; M J Parnham; V Eraković Haber
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells.

Authors:  Jae-Yeon Jeong; Jae Won Choi; Kye-Im Jeon; Dae-Myung Jue
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 4.  Bitter Taste Receptors: an Answer to Comprehensive Asthma Control?

Authors:  Ajay P Nayak; Dominic Villalba; Deepak A Deshpande
Journal:  Curr Allergy Asthma Rep       Date:  2019-09-05       Impact factor: 4.806

5.  Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.

Authors:  K-H Hong; S-A Yoo; S-S Kang; J-J Choi; W-U Kim; C-S Cho
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

6.  Chloroquine differentially modulates inflammatory cytokine expression in RAW 264.7 cells in response to inactivated Staphylococcus aureus.

Authors:  Dan Zhou; Yi Liu; Li-Hui Xu; Dong-Yun Ouyang; Hao Pan; Xiao-Yu Zhang; Gao-Xiang Zhao; Xian-Hui He
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

7.  Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.

Authors:  Rodolfo Thomé; Adriel S Moraes; André Luis Bombeiro; Alessandro dos Santos Farias; Carolina Francelin; Thiago Alves da Costa; Rosária Di Gangi; Leonilda Maria Barbosa dos Santos; Alexandre Leite Rodrigues de Oliveira; Liana Verinaud
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

Review 8.  Macrophages in rheumatoid arthritis.

Authors:  R W Kinne; R Bräuer; B Stuhlmüller; E Palombo-Kinne; G R Burmester
Journal:  Arthritis Res       Date:  2000-04-12

9.  Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin.

Authors:  Somrita Dey; Biswadev Bishayi
Journal:  J Inflamm Res       Date:  2015-01-22

Review 10.  The prince and the pauper. A tale of anticancer targeted agents.

Authors:  Alfonso Dueñas-González; Patricia García-López; Luis Alonso Herrera; Jose Luis Medina-Franco; Aurora González-Fierro; Myrna Candelaria
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.